Hande H. Tuncer MD

Education

Interests

• Malignant hematology including chronic lymphocytic leukemia and multiple myeloma
• Cancer thrombosis

News & Publications

• A Retrospective Comparison of Venetoclax Alone or in Combination With an anti-CD20 Monoclonal Antibody in R/R CLL
• Tumor Lysis, Adverse Events, and Dose Adjustments in 297 Venetoclax-Treated CLL Patients in Routine Clinical Practice
• Outcomes of Frontline Ibrutinib Treated CLL Patients Excluded from Landmark Clinical Trial
• Real-World Outcomes And Management Strategies For Venetoclax-Treated Chronic Lymphocytic Leukemia Patients In The United States
• Transfection with mRNA for CD19 Specific Chimeric Antigen Receptor Restores NK Cell Mediated Killing of CLL Cells
• An Inquiry into the Relationship between ABO Blood Group and Thrombotic Thrombocytopenic Purpura
• Umbilical Cord Mesenchymal Stem Cells Increase Expansion of Cord Blood Natural Killer Cells
• Umbilical Cord Mesenchymal Stem Cells: Adjuvants for Human Cell Transplantation
• Predictors of Response and Relapse in a Cohort of Adults with Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome: A Single-Institution Experience
• Gastrointestinal and Hepatic Complications of Hematopoietic Stem Cell Transplantation
• Hematopoietic SCT for Adult T-cell Leukemia/Lymphoma: A Review
• Photopheresis in Solid Organ Transplant Rejection
• Venetoclax As Monotherapy or in Combination: Patterns of Use and Predictors of Outcomes in an International Multicenter Study of CLL Patients
• Adverse Events, Patterns of Tumor Lysis Syndrome Prophylaxis and Management, and Dosing Patterns in a Large Cohort of Venetoclax Treated CLL Patients in Community and Academic Settings
• Treatment Patterns and Outcomes of Patients with CLL Treated with Chemoimmuno– and Novel Agent–Based Therapy: A Multicenter Study
• Mind It: Increasing Rate of Mental Health Disorders in Hospitalized Sickle Cell Patients
• Racial, Age, and Sex Disparities in Chronic Lymphocytic Leukemia (CLL) Patients Treated with Novel Therapies